X

Johnson & Johnson (JNJ) Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania

Johnson & Johnson (NYSE: JNJ) FY 2026 Other Release

Newsdesk: